To support the ongoing research efforts on Coronavirus SARS-CoV-2 causing COVID-19 disease, we've provided easy access to critical products needed for virus research and detection...
Ein gut funktionierendes QK-Labor garantiert die Integrität des Produktionsprozesses eines Unternehmens, von der Validierung der Rohmaterialien bis zur Überprüfung des fertigen Produkts...
Avantor ist bereits heute einer der wichtigsten Anbieter von speziellen Färbelösungen für das histologisch pathologische Labor. Wir erweitern täglich unser Produkt-Portfolio für unsere Kunden…
Mit seiner umfassenden Auswahl an Ausstattung für die Mikroskopie ist Avantor zu einem One-Stop-Shop für Kunden geworden, die sowohl spezielle als auch allgemeine Laborausrüstung benötigen.
Die neuen Avantor® J.T.Baker® Premium-Roboterspitzen in leitfähiger und nicht leitfähiger Ausführung liefern höchste Qualität und zuverlässige Leistung für Ergebnisse, denen Sie vertrauen können.
Avantor Services provides a wide range of specialized services and digital solutions to help you solve complex challenges.
We’ve built our reputation on consistent, comprehensive mastery of day-to-day operations, allowing lab, clinical, and production environments to focus their high-value resources on core scientific priorities.
As our customers’ needs have evolved, so have our capabilities. We have become experts in scientific operations, improving performance with sophisticated solutions and providing guidance on best practices.
You can select and customize services for peak efficiency, quality, and accelerated innovation.
VWR hat eine Reihe von neuen Dienstleistungen entwickelt, mit denen Sie Ihre Abläufe rationalisieren, Kosteneinsparungen erzielen und Ihr Labor effektiv führen...
Beschreibung:
Required during meiosis for separation of sister chromatids and homologous chromosomes. Proteolytic cleavage of REC8 on chromosome arms by separin during anaphase I allows for homologous chromosome separation in meiosis I and cleavage of REC8 on centromeres during anaphase II allows for sister chromatid separation in meiosis II (By similarity).
Beschreibung:
Required during meiosis for separation of sister chromatids and homologous chromosomes. Proteolytic cleavage of REC8 on chromosome arms by separin during anaphase I allows for homologous chromosome separation in meiosis I and cleavage of REC8 on centromeres during anaphase II allows for sister chromatid separation in meiosis II (By similarity).
Beschreibung:
Angiotensin Converting enzyme is involved in catalyzing the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This enzyme plays a key role in the renin-angiotensin system. ACE converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin. Also able to inactivate bradykinin, a potent vasodilatator. ACE exists in two forms, a 170KD somatic form and a 90KD germinal form. The somatic form is expressed by endothelial cells (especially those of lung capillaries and arterioles), epithelial cells (especially in proximal renal tubules and small intestine), by some neuronal cells and variably by some macrophages and T lymphocytes. The germinal form is expressed by spermatozoa.
Beschreibung:
Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin T) complex, also called positive transcription elongation factor B (P-TEFB), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II (RNAP II).
Beschreibung:
Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin T) complex, also called positive transcription elongation factor B (P-TEFB), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II (RNAP II).
Beschreibung:
Cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.
Beschreibung:
Die Laborwaagen Cubis® II sind modular aufgebaut und ermöglichen daher die Auswahl zwischen Anwendungen und Konfigurationen, die den Anforderungen am besten entsprechen. Diese Waagen können auf der Ebene der Anzeige, des Windschutzes, der Softwareanwendungen und der Hardwarefunktionen konfiguriert werden.
Beschreibung:
BioVanguard Greenline B is a class II cabinet range which offers simplicity, robustness and high reliability ensuring the highest level of protection for operator, product and the environment, minimising hazards inherent to working with agents assigned to biosafety levels 1, 2 and 3. BioVanguard B is designed for high risk microbiological and high toxic applications, such as the production of cytotoxic medicines.
Beschreibung:
Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin T) complex, also called positive transcription elongation factor B (P-TEFB), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (carboxy-terminal domain) of the large subunit of RNA polymerase II (RNAP II).
Beschreibung:
Cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.
Beschreibung:
Cysteine protease required for autophagy, which cleaves the C-terminal part of either MAP1LC3, GABARAPL2 or GABARAP, allowing the liberation of form I. A subpopulation of form I is subsequently converted to a smaller form (form II). Form II, with a revealed C-terminal glycine, is considered to be the phosphatidylethanolamine (PE)-conjugated form, and has the capacity for the binding to autophagosomes.